lobbying_activities: 1402909

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1402909	50f579b4-ed46-4084-8a33-d8b2a8514dac	Q2	DOWNEY MCGRATH GROUP, INC.	12573	NATIONAL ASSOCIATION OF CHAIN DRUG STORES	2013	second_quarter	HCR	All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), durable medical equipment (DME), pharmacy dispensing fees, drug safety, prescription drug diversion and abuse, drug shortages, supply chain, and issues related to compounding pharmacies.S. 557 - Medication Therapy Management Empowerment Act of 2013 H.R. 1024 - Medication Therapy Management Empowerment Act of 2013 S. 957 - Drug Supply Chain Security Act H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 S. 959 - Pharmaceutical Compounding Quality and Accountability Act H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. S. 621 - Safe Prescribing Act of 2013	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2013-07-05T10:16:57.253000-04:00